Guardian Life Insurance’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,842
| Closed | -$143K | – | 162 |
|
|
2019
Q4 | $143K | Buy |
1,842
+21
| +1% | +$1.63K | 0.03% | 136 |
|
|
2019
Q3 | $133K | Buy |
1,821
+18
| +1% | +$1.32K | 0.02% | 152 |
|
|
2019
Q2 | $111K | Buy |
1,803
+33
| +2% | +$2.03K | 0.02% | 173 |
|
|
2019
Q1 | $113K | Hold |
1,770
| – | – | 0.01% | 162 |
|
|
2018
Q4 | $90K | Hold |
1,770
| – | – | 0.02% | 176 |
|
|
2018
Q3 | $103K | Buy |
1,770
+33
| +2% | +$1.92K | 0.02% | 173 |
|
|
2018
Q2 | $84K | Buy |
1,737
+276
| +19% | +$13.3K | 0.01% | 197 |
|
|
2018
Q1 | $68K | Sell |
1,461
-588
| -29% | -$27.4K | 0.01% | 198 |
|
|
2017
Q4 | $77K | Buy |
2,049
+618
| +43% | +$23.2K | 0.02% | 242 |
|
|
2017
Q3 | $52K | Hold |
1,431
| – | – | 0.01% | 238 |
|
|
2017
Q2 | $56K | Sell |
1,431
-1,041
| -42% | -$40.7K | 0.01% | 216 |
|
|
2017
Q1 | $78K | Buy |
2,472
+15
| +0.6% | +$473 | 0.01% | 256 |
|
|
2016
Q4 | $77K | Buy |
2,457
+63
| +3% | +$1.97K | 0.01% | 262 |
|
|
2016
Q3 | $96K | Hold |
2,394
| – | – | 0.01% | 242 |
|
|
2016
Q2 | $80K | Hold |
2,394
| – | – | 0.01% | 290 |
|
|
2016
Q1 | $70K | Sell |
2,394
-675
| -22% | -$19.7K | 0.01% | 309 |
|
|
2015
Q4 | $81K | Sell |
3,069
-693
| -18% | -$18.3K | 0.01% | 316 |
|
|
2015
Q3 | $89K | Buy |
3,762
+936
| +33% | +$22.1K | 0.01% | 332 |
|
|
2015
Q2 | $67K | Hold |
2,826
| – | – | 0.01% | 351 |
|
|
2015
Q1 | $67K | Sell |
2,826
-780
| -22% | -$18.5K | 0.01% | 359 |
|
|
2014
Q4 | $77K | Hold |
3,606
| – | – | 0.01% | 387 |
|
|
2014
Q3 | $61K | Sell |
3,606
-90
| -2% | -$1.52K | 0.01% | 416 |
|
|
2014
Q2 | $53K | Hold |
3,696
| – | – | 0.01% | 446 |
|
|
2014
Q1 | $46K | Sell |
3,696
-108
| -3% | -$1.34K | ﹤0.01% | 484 |
|
|
2013
Q4 | $42K | Sell |
3,804
-4,416
| -54% | -$48.8K | ﹤0.01% | 494 |
|
|
2013
Q3 | $95K | Hold |
8,220
| – | – | 0.01% | 467 |
|
|
2013
Q2 | $92K | Buy |
+8,220
| New | +$92K | 0.01% | 459 |
|